samedan logo

home > news > detailed info

TEQ’s parent company Sonoco Joins Healthcare Plastics Recycling Council


The Healthcare Plastics Recycling Council (HPRC) is pleased to welcome Sonoco, a producer of high-quality healthcare packaging for clinical and consumer needs, as its newest member. Sonoco’s Healthcare Packaging business is part of Sonoco, a $5.2 billion global provider of diversified consumer packaging, protective packaging and packaging supply chain services.

“Sonoco Healthcare Packaging is a leader in sustainable packaging solutions,” says Peylina Chu, Executive Direct of HPRC. “Their subsidiary, TEQ, was one of the first packaging companies to adopt HPRC’s Design for Recycling Guidelines into their medical packaging. As a member of HPRC, Sonoco will help drive our vision toward an economy where all healthcare plastics are safely and effectively recycled and widely accepted as a valuable resource. Additionally, their insights and first-hand knowledge developing recyclable sterile barrier systems for the healthcare industry will directly contribute to our ongoing project work.”

Sonoco’s medical packaging solutions offer multiple plastic and environmentally friendly sterile barrier packaging systems including: TEQethyleneTM, TEQpropyleneTM and TEQconnexTM. These sterile barrier systems provide the industry with a recyclable medical packaging solution that use a proprietary blend of materials unique to each system.

“Our commitment to sustainability has been the primary driver in developing many of our products,” says Todd McDonald, Global Director of Sales and Marketing at TEQ. “In healthcare applications, we understand that for patient safety, plastic is usually the best solution. We also understand that recyclability is a critical design feature that cannot be overlooked. Being sustainable and saving lives are not mutually exclusive. I look forward to working collaboratively with HPRC to improve the recyclability of plastic products and packaging within healthcare.”

With a newly activated European chapter, HPRC Europe members are currently engaged in multiple initiatives aimed at enabling recycling of healthcare plastics, including mapping hospital barriers to recycling clinical plastics, recruiting advisory board members from European healthcare organisations, and engaging with other plastics and recycling organisations in Europe to identify areas of synergy and collaboration.

TEQ has state-of-the-art production facilities based in the UK at Hucknall Industrial Park, near Nottingham and at Poznan in Poland. Both sites have certified cleanroom facilities used to produce products for the medical sector.
phone 843-383-7000
email 1 North 2nd St. Hartsville, South Carolina 29550
Print this page
Send to a friend
News and Press Releases

Webinar to present findings from unique multidisciplinary research trials

Practical insights into lactose-based DPI formulations, with and without magnesium stearate Lactose-based dry powder inhaled (DPI) formulations are already well established in the market for the treatment of asthma and COPD. There is now a growing trend towards developing DPI formulations that are ternary mixtures including magnesium stearate as well as lactose and active pharmaceutical ingredients (APIs). The market for formulations of this kind is expanding rapidly and offers huge scope for generic players. However, the successful delivery of the active ingredient into the lungs depends on numerous interconnected factors during the production process. Therefore, the smallest change in the formulation can have a major effect on the end result.
More info >>

White Papers

Clinical Trials in Emerging Markets: Goldmines or Landmines?

Pharm-Olam, LLC

Over the past decade, biopharmaceutical companies have increasingly turned to emerging markets as a way to reduce clinical trial costs and timelines. Areas such as Eastern Europe, India, and Latin America—with their ready population of treatment naïve patients—can be an answer to the intense competition for patients seen in developed markets. Many of the countries within these regions may now be considered as “emerged” countries but yet, conducting trials in these regions does require some special attention and expertise. Before deciding to conduct studies in these areas, companies should have a full appreciation for the ethical, medical, regulatory, legal, and operational hurdles that must be surmounted for success. Here we highlight a number of those issues and offer our recommendations for how sponsor companies can deal with them effectively.
More info >>

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement